The International Society for Health Economics and Outcomes Research (ISPOR) recently released its biennial report detailing the top 10 Health Economics and Outcomes Research (HEOR) trends for 2024-2025. This report, the fifth of its kind, offers a compelling glimpse into the future of healthcare. Providing key trends such as Real-World Evidence (RWE), drug pricing, and Artificial Intelligence (AI) taking centre stage.
RWE has consistently featured in ISPOR’s reports, therefore appearing as the top trend in the three most recent publications. It is increasingly being used to supplement Randomised Controlled Trials (RCTs) in healthcare decision-making, highlighting its growing significance in the industry.
Drug pricing remains a critical concern, featuring as the second trend in the report. However, the introduction of the Inflation Reduction Act (IRA) in the United States, which allows Medicare to negotiate drug prices, could potentially impact global drug development and innovation.
AI, the third trend, is becoming an integral part of our daily lives and the healthcare sector. From chatbots to machine learning, AI is being utilised in various ways to provide valuable insights in HEOR.
Furthermore, the fourth trend focuses on fostering innovation while ensuring affordable pricing. This balance is vital for the development of new technologies in the healthcare sector.
In conclusion, the ISPOR HEOR trends report presents a comprehensive overview of the top trends shaping the future of healthcare. As pressures on healthcare systems worldwide continue to increase, these trends provide invaluable insights for stakeholders to inform and improve healthcare decisions.
💡 Can CAB-LA revolutionize HIV prevention for underserved communities?
A new study confirms CAB-LA’s cost-effectiveness as HIV PrEP, preventing 4.5 more infections per 100 users than oral PrEP and saving $42,517 in healthcare costs. It significantly benefits African American/Black MSM and cisgender women, aligning with EHE goals.
Explore how CAB-LA reshapes HIV prevention! Read the full article.
#SyenzaNews #HealthEconomics #HealthcareInnovation #CostEffectiveness
🌍 Are we truly addressing the roots of global health inequities, or are we just treating the symptoms?
In his compelling article, Jesse B. Bump dives into the historical forces shaping global health, revealing how colonial legacies and macroeconomic constraints limit our ability to achieve health equity. He challenges the status quo by urging a deeper engagement with the structures that govern resource distribution and health outcomes.
Curious to learn more about the intricate dynamics at play in global health and how they affect our collective progress?
#SyenzaNews #globalhealth #HealthEconomics #healthcarepolicy
🚀 Are you ready to explore a potential breakthrough in cancer treatment?
Recent research on neoadjuvant immunotherapy for head and neck squamous cell carcinoma unveils the promise of combination therapies, showcasing significant improvements in pathologic response and survival rates. By delving into unique T cell dynamics, this study offers a path towards personalized strategies in oncology.
Don’t miss out on the detailed insights and implications for health economics and patient care! Click to read the full article.
#SyenzaNews #oncology #HealthcareInnovation
SPEAK WITH US
CORRESPONDENCE ADDRESS
1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA
WRITE US
JOIN NEWSLETTER
